Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients
- PMID: 29218765
- DOI: 10.1111/neup.12433
Deregulation of autophagy in postmortem brains of Machado-Joseph disease patients
Abstract
Autophagy, the major pathway for protein turnover, is critical to maintain cellular homeostasis and has been implicated in neurodegenerative diseases. The aim of this research was to analyze the expression of autophagy markers in postmortem brains from Machado-Joseph disease (MJD) patients. The expression of autophagy markers in the cerebellum and the oculomotor nucleus from MJD patients and age-matched controls with no signs of neuropathology was inspected postmortem by immunohistochemistry (IHC) and Western blot. Furthermore, autophagy was examined by means of transmission electron microscopy (TEM). Western blot and IHC revealed nuclear accumulation of misfolded ataxin-3 (ATXN3) and the presence of ubiquitin- and p62-positive aggregates in MJD patients as compared to controls. Moreover, the autophagic proteins, autophagy-related gene (Atg) protein (ATG)-7, ATG-12, ATG16L2 and autophagosomal microtubule-associated protein light chain 3 (LC3) were significantly increased in MJD brains relative to controls, while beclin-1 levels were reduced in MJD patients. Increase in the levels of lysosomal-associated membrane protein 2 (LAMP-2) and of the endosomal markers (Rab7 and Rab1A) were observed in MJD patients relatively to controls. In addition, these findings were further confirmed by TEM in brain tissue where large vesicles accumulating electron-dense materials were highly enriched in MJD patients. Postmortem brains with MJD exhibit increased markers of autophagy relative to age-matched control brains, therefore suggesting strong dysregulation of autophagy that may have an important role in the course of MJD pathogenesis.
Keywords: Machado-Joseph disease (MJD) patients; ataxin-3; autophagy; cerebellum; postmortem.
© 2017 Japanese Society of Neuropathology.
Similar articles
-
Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.J Neurosci. 2017 Aug 9;37(32):7782-7794. doi: 10.1523/JNEUROSCI.1142-17.2017. Epub 2017 Jul 7. J Neurosci. 2017. PMID: 28687604 Free PMC article.
-
Fibroblasts of Machado Joseph Disease patients reveal autophagy impairment.Sci Rep. 2016 Jun 22;6:28220. doi: 10.1038/srep28220. Sci Rep. 2016. PMID: 27328712 Free PMC article.
-
The autophagy-enhancing drug carbamazepine improves neuropathology and motor impairment in mouse models of Machado-Joseph disease.Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12763. doi: 10.1111/nan.12763. Epub 2021 Oct 13. Neuropathol Appl Neurobiol. 2022. PMID: 34432315
-
Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics.Int J Mol Sci. 2023 Apr 17;24(8):7405. doi: 10.3390/ijms24087405. Int J Mol Sci. 2023. PMID: 37108570 Free PMC article. Review.
-
Machado-Joseph Disease: A Stress Combating Deubiquitylating Enzyme Changing Sides.Adv Exp Med Biol. 2020;1233:237-260. doi: 10.1007/978-3-030-38266-7_10. Adv Exp Med Biol. 2020. PMID: 32274760 Review.
Cited by
-
Small Molecules Inducing Autophagic Degradation of Expanded Polyglutamine Protein through Interaction with Both Mutant ATXN3 and LC3.Int J Mol Sci. 2024 Oct 4;25(19):10707. doi: 10.3390/ijms251910707. Int J Mol Sci. 2024. PMID: 39409036 Free PMC article.
-
Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases.Sci Rep. 2019 Mar 8;9(1):3965. doi: 10.1038/s41598-019-39828-5. Sci Rep. 2019. PMID: 30850634 Free PMC article.
-
Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and Beyond.Biomed Res Int. 2019 Feb 14;2019:4741252. doi: 10.1155/2019/4741252. eCollection 2019. Biomed Res Int. 2019. PMID: 30895192 Free PMC article. Review.
-
Endosome mediated nucleocytoplasmic trafficking and endomembrane allocation is crucial to polyglutamine toxicity.Cell Biol Toxicol. 2024 Jun 20;40(1):48. doi: 10.1007/s10565-024-09891-4. Cell Biol Toxicol. 2024. PMID: 38900277 Free PMC article.
-
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies.Biomedicines. 2021 Oct 20;9(11):1499. doi: 10.3390/biomedicines9111499. Biomedicines. 2021. PMID: 34829728 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous